A DTAP–IPV//PRP~T VACCINE: A REVIEW OF 16 YEARS’ CLINICAL EXPERIENCE
Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP)-inactivated poliovirus (IPV) combined vaccines are now included in various national immunization programs worldwide. We provide an overview of 16 years of clinical experience with...
Saved in:
| Main Authors: | Stanley A. Plotkin, Johannes Liese, Shabir A. Madhi, Esteban Ortiz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2012-01-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/507 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019-09-01) -
Vaccine interchangeability: problems and prospects
by: N. A. Gavrilova, et al.
Published: (2021-10-01) -
Safety, immunogenicity, and efficacy of Borrelia burgdorferi outer surface protein A (OspA) vaccine: A meta-analysis
by: Hua Zhao, et al.
Published: (2017-01-01) -
Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia
by: Thamir A. Alandijany, et al.
Published: (2025-08-01) -
Prospective study of safety, immunogenicity, and efficacy of inactivated COVID-19 vaccine in tuberous sclerosis complex children on sirolimus
by: Sufang Lin, et al.
Published: (2025-12-01)